Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5190)
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
1,800
Price
$15.00
Total Value
$27.00K
Shares Held After
213,867
% of Holdings
0.8%
Edwards Lifesciences Corp (EW)
Ullem Scott B. — CVP, Chief Financial Officer
Shares
8,324
Price
$79.79
Total Value
$664.14K
Shares Held After
39,699
% of Holdings
17.3%
Edwards Lifesciences Corp (EW)
Ullem Scott B. — CVP, Chief Financial Officer
Shares
4,676
Price
$80.50
Total Value
$376.40K
Shares Held After
48,023
% of Holdings
8.9%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
5,000
Price
$5.19
Total Value
$25.95K
Shares Held After
3,032,000
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
200
Price
$85.00
Total Value
$17.00K
Shares Held After
1,132,987
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
2,000
Price
$83.26
Total Value
$166.52K
Shares Held After
1,133,187
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
17,800
Price
$82.48
Total Value
$1.47M
Shares Held After
1,135,187
% of Holdings
1.5%
908 Devices Inc. (MASS)
McCallion Kevin J. — SVP, Products and Production
Shares
18,580
Price
$7.05
Total Value
$130.99K
Shares Held After
44,925
% of Holdings
29.3%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
15,030
Price
$7.05
Total Value
$105.96K
Shares Held After
970,529
% of Holdings
1.5%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
22,564
Price
$15.07
Total Value
$340.04K
Shares Held After
271,154
% of Holdings
7.7%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
10,000
Price
$14.85
Total Value
$148.50K
Shares Held After
1,512,058
% of Holdings
0.7%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
130,862
Price
$16.91
Total Value
$2.21M
Shares Held After
4,071,637
% of Holdings
3.1%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
353,242
Price
$16.32
Total Value
$5.76M
Shares Held After
4,202,499
% of Holdings
7.8%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
332
Price
$311.59
Total Value
$103.45K
Shares Held After
0
% of Holdings
100.0%
Roivant Sciences Ltd. (ROIV)
Humes Jennifer — Chief Accounting Officer
Shares
13,538
Price
$28.37
Total Value
$384.07K
Shares Held After
84,191
% of Holdings
13.9%
Crinetics Pharmaceuticals, Inc. (CRNX)
Knight Jeff E. — Chief Dev. & Operating Officer
Shares
85,163
Price
$40.10
Total Value
$3.42M
Shares Held After
105,289
% of Holdings
44.7%
Ginkgo Bioworks Holdings, Inc. (DNA)
Canton Barry — 10% Owner
Shares
13,155
Price
$6.93
Total Value
$91.16K
Shares Held After
351,684
% of Holdings
3.6%
Ginkgo Bioworks Holdings, Inc. (DNA)
Kelly Jason R — Director
Shares
97,015
Price
$6.93
Total Value
$672.31K
Shares Held After
426,250
% of Holdings
18.5%
Ginkgo Bioworks Holdings, Inc. (DNA)
Shetty Reshma P. — Director
Shares
13,155
Price
$6.93
Total Value
$91.16K
Shares Held After
351,684
% of Holdings
3.6%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
8,722
Price
$24.83
Total Value
$216.57K
Shares Held After
245,222
% of Holdings
3.4%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
2,800
Price
$4.84
Total Value
$13.55K
Shares Held After
3,726,150
% of Holdings
0.1%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
5,165
Price
$24.83
Total Value
$128.25K
Shares Held After
183,231
% of Holdings
2.7%
Omada Health, Inc. (OMDA)
Shao Wei-Li — President
Shares
2,829
Price
$12.71
Total Value
$35.95K
Shares Held After
328,850
% of Holdings
0.9%
EXOZYMES INC. (EXOZ)
Korman Tyler Paz — Chief Scientific Officer
Shares
750
Price
$10.04
Total Value
$7.53K
Shares Held After
729,873
% of Holdings
0.1%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,518
Price
$24.83
Total Value
$37.69K
Shares Held After
254,439
% of Holdings
0.6%
SOPHiA GENETICS SA (SOPH)
Valente Manuela — Chief People Officer
Shares
3,824
Price
$4.85
Total Value
$18.54K
Shares Held After
215,451
% of Holdings
1.7%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
8,614
Price
$24.83
Total Value
$213.89K
Shares Held After
255,957
% of Holdings
3.3%
SOPHiA GENETICS SA (SOPH)
Muken Ross — President
Shares
2,786
Price
$4.84
Total Value
$13.49K
Shares Held After
695,311
% of Holdings
0.4%
SOPHiA GENETICS SA (SOPH)
Van Well Daan — Chief Legal Officer
Shares
2,861
Price
$4.85
Total Value
$13.86K
Shares Held After
350,808
% of Holdings
0.8%
SOPHiA GENETICS SA (SOPH)
CARDOZA GEORGE — Chief Financial Officer
Shares
1,403
Price
$4.85
Total Value
$6.80K
Shares Held After
291,458
% of Holdings
0.5%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
2,800
Price
$4.84
Total Value
$13.55K
Shares Held After
642,152
% of Holdings
0.4%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
2,800
Price
$4.84
Total Value
$13.54K
Shares Held After
278,652
% of Holdings
1.0%
DAXOR CORP (DXR)
Feldschuh Michael Richard — Director
Shares
1,000
Price
$9.07
Total Value
$9.07K
Shares Held After
213,694
% of Holdings
0.5%
GRAIL, Inc. (GRAL)
Freidin Aaron — Chief Financial Officer
Shares
45,806
Price
$49.92
Total Value
$2.29M
Shares Held After
260,669
% of Holdings
14.9%
GRAIL, Inc. (GRAL)
RAGUSA ROBERT P — Director
Shares
123,502
Price
$49.92
Total Value
$6.16M
Shares Held After
518,582
% of Holdings
19.2%
GRAIL, Inc. (GRAL)
Ofman Joshua J. — Director
Shares
61,665
Price
$49.92
Total Value
$3.08M
Shares Held After
371,216
% of Holdings
14.2%
Adicet Bio, Inc. (ACET)
ORBIMED ADVISORS LLC — 10% Owner
Shares
40,416
Price
$6.52
Total Value
$263.51K
Shares Held After
0
% of Holdings
100.0%
Adicet Bio, Inc. (ACET)
ORBIMED ADVISORS LLC — 10% Owner
Shares
32,523
Price
$6.29
Total Value
$204.57K
Shares Held After
0
% of Holdings
100.0%
Protara Therapeutics, Inc. (TARA)
Zummo Jacqueline — Chief R&D Officer
Shares
1,134
Price
$5.40
Total Value
$6.12K
Shares Held After
94,827
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$585.48
Total Value
$163.93K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
486
Price
$584.47
Total Value
$284.05K
Shares Held After
40,793
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,874
Price
$583.44
Total Value
$1.09M
Shares Held After
41,279
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,166
Price
$582.49
Total Value
$1.26M
Shares Held After
43,153
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,337
Price
$581.72
Total Value
$777.75K
Shares Held After
45,319
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
477
Price
$580.59
Total Value
$276.94K
Shares Held After
46,656
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$579.22
Total Value
$278.03K
Shares Held After
47,133
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$578.08
Total Value
$346.85K
Shares Held After
47,613
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$577.07
Total Value
$323.16K
Shares Held After
48,213
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$575.86
Total Value
$299.45K
Shares Held After
48,773
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$572.12
Total Value
$68.65K
Shares Held After
49,293
% of Holdings
0.2%
Showing 3351–3400 of 5190 transactions (page 68 of 104)